Guggenheim Capital’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-46,985
| Closed | -$2.09M | – | 2223 |
|
|
2018
Q3 | $2.09M | Sell |
46,985
-76
| -0.2% | -$3.37K | 0.01% | 1217 |
|
|
2018
Q2 | $1.85M | Buy |
47,061
+11,547
| +33% | +$453K | 0.01% | 1297 |
|
|
2018
Q1 | $2.57M | Sell |
35,514
-4,014
| -10% | -$290K | 0.01% | 1453 |
|
|
2017
Q4 | $2.6M | Sell |
39,528
-15,567
| -28% | -$1.03M | 0.01% | 1467 |
|
|
2017
Q3 | $2.76M | Buy |
55,095
+3,428
| +7% | +$172K | 0.01% | 1437 |
|
|
2017
Q2 | $2.39M | Buy |
+51,667
| New | +$2.39M | 0.01% | 1506 |
|
|
2015
Q4 | – | Sell |
-8,496
| Closed | -$200K | – | 3012 |
|
|
2015
Q3 | $200K | Sell |
8,496
-30,993
| -78% | -$730K | ﹤0.01% | 2734 |
|
|
2015
Q2 | $3.23M | Buy |
+39,489
| New | +$3.23M | 0.01% | 1404 |
|